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Introduction: Psychiatric morbidity appears common in fatal and near-fatal asthma
and may be a factor in difficult to control asthmatic subjects. We examined the
prevalence of psychiatric morbidity (using psychiatric interview) in a cohort of
sequentially referred poorly controlled asthmatics and related this to (a) asthma
outcome (b) assessing chest physician opinion and (c) Hospital Anxiety Depression
Scale (HADS).
Methods: Patients were evaluated using a systematic evaluation protocol to identify
and manage all co-morbidity. Psychiatric assessment was performed by experienced
liaison psychiatrists and ICD10 diagnosis and treatment programme assigned.
Subjects completed HADS at presentation and follow-up. Asthma was managed
according to BTS/SIGN Guidelines.
Results: Of 65 subjects who attended for psychiatric interview, 32 (49%) had an
ICD10 diagnosis, (6 (9%) previously identified) with depression most common (59%).
Physician assessment had poor discrimination for psychiatric illness. Anxiety scores
(13.470.8 vs. 8.570.7) and depression scores (10.270.7 vs. 4.870.5) scores were
significantly higher in subjects with ICD10 diagnosis (Po0:001), who were also more
likely to be current smokers (Po0:01). HADS had a poor positive predictive value for
psychiatric illness but a good negative predictive value for depression. There was no
relationship between ICD10 diagnosis and asthma outcome. Subjects identified as
therapy-resistant asthma after systematic evaluation, had significantly lower
depression scores after treatment (Po0:05).
Conclusion: In difficult asthmatics, there is a high prevalence of undiagnosed
psychiatric morbidity, with depression being particularly prevalent. A simple
screening questionnaire such as HADS, has a high false positive rate when comparedElsevier Ltd. All rights reserved.
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appears to be little association between identification and management of co-
existent psychiatry morbidity and asthma outcome.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Most adult patients with asthma respond to therapy
with moderate doses of inhaled corticosteroids
alone or in addition to a long-acting b2-agonist.
Approximately 5% of adult patients remain difficult-
to-control despite high-dose inhaled steroids1 and
debate exists as to the next best therapeutic
intervention,2 but these patients are a cause of
concern because of persistent symptoms and
impairment of quality of life, continued impaired
lung function, increased risk of asthma deaths and
adverse effects of high-dose corticosteroids.1,3
It is likely that a number of factors contribute to
the lack of adequate control in these subjects, and
psychiatric disorder has been proposed as a
modulator of difficult asthma.1,3,4 A number of
retrospective confidential enquiries into asthma
death and case control studies in near-fatal
asthma5–7 have demonstrated an association with
psychiatric morbidity and recent life events,
though this has not been the case universally.8,9
Hospital admission with asthma is also associated
with psychiatric morbidity though this does not
appear to differ in those who present with a near-
fatal attack10 and more recently increased psychia-
tric morbidity has been shown to predict relapse
after treatment for acute asthma.11
In subjects with chronic persistent asthma, a
number of studies, using screening questionnaires,
have shown increased evidence of morbidity in
asthmatic patients with evidence of increased
anxiety, depression and poor coping skills.12–14 In
the Managed Care Outcomes Project15 looking at
optimal clinical outcomes using the Clinical Prac-
tice Improvement (CPI) model, depression ac-
counted for the majority of psychiatric diagnoses.
In this study, psychiatric illness was under-diag-
nosed and associated with more severe asthma,
which has been suggested by other authors,16
though this association between psychopathology
and asthma severity has not been consistently
present.17 Ten Brinke has suggested that increased
health service utilisation and thus costs are related
to the level of psychological dysfunction in patients
with difficult-to-control asthma.18 In patients with
asthma, symptom scores appeared to correlate
better with degree of anxiety and depression than
with lung function, suggesting it may be the
interpretation of symptoms which is more relevantthan the degree of physiological impairment.16,19
Brittle asthma, a particular sub-type of difficult-to-
control asthma, is also associated with psychiatric
morbidity.20
Given the association between fatal/near-fatal
asthma and psychiatric morbidity and the sugges-
tion of increased psychiatric morbidity in subjects
with chronic persistent asthma, we hypothesised
that there would be a high prevalence of undiag-
nosed psychiatric morbidity in a difficult-to-control
asthma population. We also hypothesised that
when psychiatric illness was identified and appro-
priately managed, this would be associated with an
improved asthma outcome. In addition, we wished
to examine the relationship between formal psy-
chiatric diagnostic interview and the Hospital
Anxiety Depression Scale (HADS),21 a commonly
used screening tool for psychiatric morbidity, in
patients attending hospital. To test these hypoth-
eses, we performed formal psychiatric assessment
and HADS questionnaire, as part of a systematic
evaluation protocol, in a sequentially referred
population of difficult-to-control asthmatics.Methods
The details of the systematic evaluation protocol
and management has been published elsewhere.22
In brief, patients were recruited for protocol
evaluation, if they had (1) persisting refractory
symptoms prompting referral, (2) minimal main-
tenance therapy of long-acting b2-agonist and
inhaled steroids (X800 mg BDP or equivalent) and
(3) at least 1 course of systemic steroids in
preceding 12 months. Asthma was defined on the
basis of symptoms together with current or
previously documented reversible airflow obstruc-
tion (forced expiratory volume at 1 s of 412%
either spontaneously or with medication).23 Pa-
tients were recruited to the protocol in a sequen-
tial, unselected manner. The protocol was run on
an outpatient basis and co-ordinated by an asthma
nurse specialist.
At the initial visit, a detailed semi-structured
clinical history, which in part focussed on the
presence of background psychosocial problems,
was recorded on all subjects and full physical
examination was performed. Based on the clinical
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after this assessment was graded by the assessing
physician (LH in all cases) as 0 (not present), 1
(minor factor) and 2 (major factor). The evaluation
protocol involved skin prick testing to 12 inhalant
allergens, chest X-ray and spirometric testing with
reversibility to nebulised b2-agonist, urinalysis, a
standardised battery of blood tests and induced
sputum, which were all performed at Visit 1.
Asthma-related quality of life and HADS were
completed at Visit 1. Asthma-related quality of life
was assessed using the Juniper scale.24 The
response options for each of the 32 items are on a
7-point scale, ranging from 1 (totally limited) to 7
(not at all limited) and a clinically minimal
significant change in overall score is 0.5.25 Anxiety
and depression scores were measured using the
HADS.21 The HADS defines a score of 0–7 as normal,
8–10 as being mildly disturbed and 11 or more as
definite psychiatric caseness or subjects who
require psychiatric assessment.
The following investigations were arranged as
part of the investigative protocol: formal psychia-
tric interview, ear, nose and throat examination,
pulmonary function testing (inspiratory/expiratory
flow volume loop, carbon monoxide transfer factor
and lung volumes by helium dilution), high-resolu-
tion CT scan of thorax, 24 h dual probe ambulatory
oesophageal pH monitoring and dual emission X-ray
absorptimetry (DEXA) scan. All subjects were
offered the services of a social worker, if an
underlying contributory social issue was identified
either by the chest physician or after psychiatric
evaluation. Any identified co-existent morbidity
was managed using standard intervention and
therapies as previously described.22
Asthma was managed according to BTS Guide-
lines with treatment being stepped up and down
as appropriate.2 The lowest dose of inhaled
corticosteroid required to control their asthma
during the period of evaluation was recorded.
Therapy-resistant asthma (TRA) was defined in
accordance with the ERS Task Force on Difficult
Asthma; specifically persisting symptoms due to
asthma despite high-dose inhaled steroids (2000 mg
beclomethasone, 1600 mg budesonide, 1000 mg
fluticasone) plus long-acting beta-agonist with
the requirement for either maintenance systemic
steroids or at least 2 rescue courses of steroids
during a follow-up period of 12 months and despite
trials of other add-on therapies e.g. leukotriene
receptor antagonist or theophylline. In subjects
with non-therapy-resistant asthma, asthma-related
quality of life and HAD were completed on
discharge and in TRA, 12–18 months after protocol
assessment.Psychiatric evaluation
All patients were offered a formal psychiatric
interview as part of their evaluation protocol.
Psychiatric diagnoses were determined by a sys-
tematic clinical interview performed by experi-
enced liaison psychiatrists (EC and CK) following
the guidelines of the International Classification of
Diseases (ICD10) of Mental and Behavioural dis-
orders. The psychiatrists were aware that patients
had difficult-to-control asthma but no other back-
ground clinical or demographic information prior to
assessment. In cases where there was any uncer-
tainty over clinical diagnosis a consensus was
reached between EC and CK. After assignation of
diagnosis, an individual treatment programme was
designed. Referral was made to local psychiatric
services, clinical psychology and/or social work
services if appropriate or pharmacotherapy was
initiated with GP and CPN involvement.
Statistical analysis
Demographic data are presented as mean7
standard error of the mean, or as the absolute
value. Univariate analysis was performed using
unpaired t-test for continuous variables, and Chi-
square (w2) analysis for dichotomous variables. All
statistics were performed using SPSS for Windows
Version 11.Results
Over an 18-month recruitment period, 86 patients
were referred to the service, and of these, 6 were
omitted at Visit 1, because they did not fulfil
our entry criteria at the time of first attendance
(4 were not taking a long-acting beta-agonist
despite its apparent prescription and 2 were no
longer difficult to control). Of the remaining 80
subjects, 6 were lost to analysis (4 subjects were
non-compliant with the protocol, 1 subject had
oesophageal adenocarcinoma diagnosed during
evaluation, 1 subject emigrated). In 1 further
subject, a diagnosis of asthma could not be
sustained after review of attendance and serial
lung function.
Of the remaining 73 subjects, 34 were classified
as TRA after evaluation. Of these 73 subjects, 8
(11%) subjects did not have a psychiatric assess-
ment (4 refused assessment, 1 lost referral, 1
cognitive impairment (congenital), 1 already at-
tending clinical psychology, 1 failed to attend),
though none of the therapy-resistant group refused
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remaining 65 subjects are shown in Table 1.
Psychiatric morbidity was common; 32 (49%) had
an ICD10 psychiatric diagnosis and of these only 6
(9%) had been previously identified and were
receiving current treatment. Subjects with a
psychiatric illness were more likely to be current
smokers (Table 1). Depressive illness (F32) was the
most common diagnosis (19 [59%]) followed by
generalised anxiety disorder (F41.1) (5 [16%]). The
other 8 subjects had a variety of conditions; post-
traumatic stress disorder (F43.1), acute stress
reaction (F43.0), specific phobia (F40.2), eating
disorder (F50), organic affective disorder (F06.3),
persistent delusional disorder (F22), anankastic
personality disorder (F60.5) and mixed personality
disorder (F60.9). There was no difference in the
overall prevalence of psychiatric illness, undiag-
nosed psychiatric illness or depression in subjectsTable 1 Demographic variables at presentation in al
psychiatric diagnosis.
All subjects
(n ¼ 65)
Sub
ICD
dia
Age (y) 43.871.8 44.
Female (%) 44 (68) 20
Age of asthma diagnosis (y) 22.772.2 21.
Period of instability (m) 54.878.6 64.
Asthma duration (y) 21.172.0 22.
Smoker
Current 11 1
Ever 12 6
Atopy (%) 35 (54) 20
Rescue steroid courses (preceding
12 months)
4.370.4 3.7
Hospital admission (preceding 12
months)
0.8270.2 0.8
Unscheduled visits (preceding 12
months)
5.371.4 6.4
Inhaled steroid at referral (mg
BDP equivalent)y
24067160 242
Maintenance systemic steroid at
referral
19 11
Pre-bronchodilator FEV1 (L) 2.070.10 1.9
Pre-bronchodilator FEV1% 7173 667
FVC % 8375 787
FEV1/FVC ratio (%) 6872 657
RV (%) 12976 125
TLC (%) 10972 108
TLCO (%) 9373 937
Therapy-resistant asthma (%) 33 (51) 17
Unscheduled visits include visits to primary care and hospital
yBioequivalence of inhaled steroids was fluticasone ¼ 2b
mean7standard error or absolute values.with TRA compared to subjects who responded to
systematic evaluation and management. (Table 2).
In subjects with undiagnosed psychiatric illness,
specific management was defined at time of
assessment. In subjects with depression, 8 were
classed as having mild depressive illness, 9 had
moderate depressive illness and 2 were classified as
severe clinical depression. Subjects with depres-
sion were treated as clinically appropriate accord-
ing to need, with either a selective serotonin
reuptake inhibitor (SSRI) or a serotonin noradrena-
line reuptake inhibitor (SNRI) and linked with
psychiatric services as necessary. Subjects with
anxiety and stress disorders were referred to
clinical psychology service involving subsequent
cognitive behavioural therapy and a stress manage-
ment programme. The subject with persistent
delusional disorder was commenced on Olanzapine
and assessed urgently by psychiatric services. Thel subjects and patients with and without an ICD10
jects with no
10 psychiatric
gnosis (n ¼ 33)
Subjects with an
ICD10 psychiatric
diagnosis (n ¼ 32)
P-value
272.6 43.472.5 ns
(61) 24 (75) ns
773.4 23.772.8 ns
9715.1 44.477.5 ns
573.3 19.772.1 ns
10 Po0:01
6 ns
(61) 15 (47) ns
70.5 4.770.7 ns
70.3 0.970.3 ns
72.6 4.370.8 ns
17230 23907227 ns
8 ns
670.16 2.1270.14 ns
4 7675 ns
5 8879 ns
2 7272 Po0:05
78 13578 ns
73 11073 ns
4 9273 ns
(52) 16 (50) ns
accident and emergency departments.
eclomethasone ¼ 2budesonide. Data are presented as
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Table 2 Distribution of ICD10 diagnoses and physician scores at presentation in all subjects and subjects with
therapy-resistant asthma and non-therapy-resistant asthma after evaluation.
All patients
(n ¼ 65)
Therapy-resistant
asthma (n ¼ 33)
Non-therapy-
resistant asthma
(n ¼ 32)
P-value
ICD10 psychiatric illness (%) 32 (49) 16 (48) 16 (50) ns
Unrecognised psychiatric illness (%) 26 of 32 (81) 15 of 16 (94) 11 of 16 (69) ns
Depressive illness (%) 19 of 32 (59) 9 of 16 (56) 10 of 16 (62) ns
Physician clinical score (% scoring
0,1,2)
51, 34, 15 58, 36, 6 44, 31, 25 ns
Clinical scores, relating to the presence of a psychological factor, were graded by the assessing physician on the basis of
clinical history and graded 0 (not present), 1 (minor factor), 2 (major factor).
L.G. Heaney et al.1156subject with organic affective disorder was proble-
matic in that she had steroid-dependent asthma
but developed mild hypomania/aggression when on
high-dose systemic steroids. She was managed by
taking Chlorpromazine when she was on high-dose
steroids. The subject with eating disorder had
ongoing contact with psychotherapy services. The
subject with mixed personality disorder engaged in
analytic psychotherapy. The subject with anankas-
tic personality disorder refused any form of
support.
When the respiratory physician (LH) scored 0 for
psychiatric illness, 21 of 33 had no ICD10 psychiatric
diagnosis but 12 did, when he graded 1, 11 out of 22
had a psychiatric diagnosis, when physician graded
2, 9 out of 10 had a psychiatric diagnosis (Table 2).
Anxiety scores (13.470.8 vs. 8.570.7) and
depression scores (10.270.7 vs. 4.870.5) scores
with HADS were significantly higher in subjects with
an ICD10 diagnosis (Po0:001). Defining a HAD score
of 8 or above as abnormal, the positive predictive
value (PPV) and negative predictive value (NPV) for
all psychiatric illness were 59% and 86%, respec-
tively, and for depressive illness PPV 44%, NPV 92%.
Defining a HAD score of 11 or above as abnormal,
the PPV and NPV for all psychiatric illness were 74%
and 73%, respectively, and for depressive illness
PPV 67%, NPV 89%.
Significant and clinically relevant improvements
in asthma-related quality of life was noted in the
group defined as responders supporting the clinical
diagnosis of responsive asthma (Table 3). This was
not observed in the therapy-resistant group con-
sistent with their disease-specific quality of life
being unchanged despite extensive investigation
and management of all identified provoking fac-
tors. Anxiety and depression scores were identical
at presentation in both groups. At discharge/
follow-up, depression scores were significantly
better in the therapy-resistant group (Po0:05;
Table 3) but not in the responsive group.Discussion
This study demonstrates a high prevalence (49%) of
psychiatric morbidity in subjects referred with
difficult-to-control asthma, with only 9% of having
been previously recognised. Our most common
diagnosis was depressive illness (29%), which is
consistent with Mancuso and colleagues, who
detected depressive symptoms in almost half of
subjects with moderate asthma using a variety of
screening tools.26 Nascimento, using the Mini-
International Neuropsychiatric Interview (MINI)
questionnaire, had depression rates of 33.7% and
Brown using clinical interview with patients with
moderate to severe disease found current depres-
sive disorder of 25% which was again largely
undiagnosed.14,27 Since depressive illness is com-
mon and has been associated with poor medication
compliance, loss to follow-up28 and asthma
death,5,6 identification and treatment of depres-
sion is potentially important in this population.
There are limitations to the psychiatric assess-
ment in this study, in that ICD10 diagnoses were not
supported by research diagnostic interviews. This
was a pragmatic study looking at the clinical
psychiatric diagnosis in a hierarchical manner in
this particular group of asthma patients. The goal
of the psychiatric assessment was to assign the
most severe primary psychiatric diagnosis, to which
treatment could be directed and this is reported in
this study. This represents a standard clinical
approach to psychiatric assessment and treatment
and an assessment strategy that can be reasonably
delivered in this group of patients. We are unable
to comment on the prevalence of psychiatric
morbidity, assessed by psychiatric interview, in
subjects with mild asthma as our study did not
have such a control group, and we are unaware of
any previous study, which has used psychiatric
interview as the main assessment tool, in subjects
with mild to moderate disease.
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Table 3 Asthma Quality of Life and Anxiety and Depression Scores at presentation and discharge (therapy-
responsive asthma) or follow-up (therapy-resistant asthma—12–18 months after referral), in all subjects and
subjects with therapy-resistant asthma and non-therapy-resistant asthma after evaluation.
Visit 1
presentation
Visit 2—discharge/
follow-up [95% CI for
mean change]
P-value
Asthma QoL score
Therapy-resistant asthma 3.370.21 3.570.25 P ¼ ns
[95% CI] [0.01–0.69]
Non-therapy-resistant asthma 3.170.17 4.2470.30 Po0:001
[95% CI] [0.54–1.6]
HAD anxiety scorey
Therapy-resistant asthma 10.770.9 10.071.0 P ¼ ns
Non-therapy-resistant asthma 11.271.0 10.071.0 P ¼ ns
HAD depression scorey
Therapy-resistant asthma 7.570.9 6.370.7 Po0:05
Non-therapy-resistant asthma 7.570.7 6.871.0 P ¼ ns
Asthma-related quality of life was assessed using the Juniper scale.24 The response options for each of the 32 items are on a
7-point scale, ranging from 1 (totally limited) to 7 (not at all limited) and a clinically minimal significant change in overall score
is 0.5 (Juniper et al.25).
yAnxiety and depression scores were measured using the Hospital Anxiety and Depression scale (Zigmond et al.21—scores are
categorised as normal 0–7, mild 8–10, moderate 11–14, severe 15–21). Data are presented as mean7standard error or absolute
values unless stated otherwise.
Prevalence of psychiatric morbidity in a difficult asthma 1157It may not always be possible for hospital difficult
asthma services to have a psychiatrist present;
therefore, it becomes important for us to include
ways of detecting psychiatric morbidity that can be
incorporated simply into respiratory clinics. When
the chest physician was scoring the contribution of
psychiatric illness to the difficult asthma, if he felt
a psychiatric condition was a major contributing
factor he was likely to be correct (9 out of 10 cases)
but when he felt it was not present or a minor
factor he was at least as likely to be wrong (23 from
55). This was despite a semi-structured clinical
evaluation designed to detect psychosocial pro-
blems and administered by a focused respiratory
physician and suggests that chest physicians are
likely to miss significant underlying psychiatric
illness.
Because of this, the use of screening tools may
help the physician to detect morbidity and to refer
for assessment. We used the Hospital Anxiety and
Depression scale, which is a commonly used tool in
hospital outpatient settings and determined nega-
tive and positive predictive values for detecting all
morbidity and the commonest condition, depressive
illness. The major problem in detecting all psychia-
tric illness using any abnormal score was the poor
PPV i.e. false positives. Increasing the threshold
score to 11 improved this to a degree but still
resulted in a high false positive value. Thisobservation questions the validity of studies using
general psychological screening tools in isolation,
and may explain some reported very high preva-
lence of psychiatric morbidity using such instru-
ments.13,14,20 Whilst there may be differences
between different questionnaires, we would suggest
that such screening questionnaires need validation
in specific asthmatic populations, because many of
the questions particularly with regard to anxiety
symptoms may be interpreted and answered differ-
ently by subjects with asthma. The breadth of other
psychiatric diagnoses in our series should also be
noted which reached the level of psychosis in 2
cases. Single diagnosis screening instruments could
potentially misidentify significant pathology. In
addition, we chose to assign only one psychiatric
diagnosis with depression ahead of anxiety in our
ICD10 hierarchy, since depressive illness is often
associated with anxiety symptoms and treating the
depressive illness often causes resolution of these.
This again highlights the discriminatory problems
with screening questionnaires and supports using a
formal psychiatric interview to diagnose specific
psychiatric illness in this group.
The NPV for all psychiatric illness was better and
suggests that an underlying psychiatric diagnosis is
unlikely (though not excluded) when both anxiety
and depression scores are normal. The depression
score is particularly useful because if this is normal
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individual diagnosis) is minimal.
We also hypothesised that detection and treat-
ment of psychiatric illness would be associated with
improved asthma outcome. This is not supported by
the observation of a similar prevalence of psychia-
tric illness in those whose asthma improved,
compared to those who failed to respond to
intervention and the lack of change in asthma-
related quality of life in the latter group despite
psychiatric evaluation and treatment. In addition,
in the group with the better asthma outcome, there
was no change in their anxiety and depression
scores, whilst in the therapy-resistant group,
depression scores were significantly improved. Our
findings suggest some dissociation between psy-
chiatric and asthma outcome in this population,
and suggest that the potential role of background
psychopathology in difficult asthma is not a
straightforward one. We appreciate that to fully
examine the relationship between treatment of
psychiatric disorder and asthma outcome, a rando-
mised controlled trial would be required, but given
the range of psychiatric diagnoses observed and the
different therapeutic requirements, such a trial
may be impractical. However, we still believe that,
given the considerable prevalence of psychiatric
disorder in this population, routine assessment and
management of psychiatric morbidity should be
performed.
In conclusion, undetected psychiatric illness is
common in a group of sequentially referred
difficult-to-control asthmatics, with depression
being particularly prevalent. A simple screening
questionnaire such as HADS has a high rate of false
positives when compared to psychiatric interview,
but may be useful in excluding depressive illness.
There does not appear to be straightforward
association between identification and manage-
ment of co-existent psychiatry morbidity and
improved asthma outcome in difficult asthma.References
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